Wall Street ended a choppy Wednesday with a split verdict. The Dow lost more than 1% as health insurers were hammered by a federal audit proposal. The Nasdaq edged higher on gains in cybersecurity and retail shares.
The S&P 500 slipped for a fifth consecutive session, its longest losing run in some time. A hawkish message from the Federal Reserve kept nerves frayed.
How the major indexes finished
- Dow Jones Industrial Average: down 561.25 points, or 1.11%, at 50,198.17
- S&P 500: down 16.90 points, or 0.23%, at 7,323.63
- Nasdaq Composite: up 101.50 points, or 0.42%, at 24,429.88
- Russell 2000: up 12.44 points, or 0.46%, at 2,714.31
The VIX, Wall Street’s main gauge of expected volatility, stood near 24.6. That is a level that points to unease rather than panic.
Insurers take the brunt
The heaviest damage came from health insurers. The trigger was a proposal from the Centers for Medicare & Medicaid Services (CMS) to tighten oversight of Medicare Advantage, the privately run version of the government health programme for older Americans.
Under the plan, audit findings would be extrapolated across entire insurance contracts, with the look-back stretching to payment year 2018. In practice, errors found in a sample of patient charts could be applied to a whole contract. CMS estimates the approach would recover about $9 billion for each payment year across the industry. The agency’s administrator, Mehmet Oz, has framed the effort as a crackdown on fraud, waste and abuse.
The proposal had already unsettled the sector earlier in the week. Wednesday’s selling was heavier:
- UnitedHealth fell 10.21%
- Humana dropped 12.98% to $385.78, the worst performer in the S&P 500
- Elevance Health lost 7.63%
- CVS Health declined about 5.2%
- Cigna shed 3.0%
UnitedHealth is a Dow component, and its slide did much of the damage to the blue-chip index. It is also the largest Medicare Advantage insurer. Government premiums accounted for about 44% of its revenue in 2025, according to analysts. The company has not put a figure on its potential exposure, and it has promised its 2027 outlook before the end of the year.
Investors should note that the proposal is not final. The public comment period runs until 19 January 2027, so the rule could change before it takes effect.
Nvidia fails to lift the mood
Technology shares were mixed. Nvidia fell 2.89%, its fifth straight decline, despite reporting results that beat expectations. Its stock has been caught up in a broader debate about AI spending and the company’s leadership transition.
Gains in cybersecurity and retail names helped the Nasdaq finish in positive territory.
Rates and oil
Minutes from the Fed’s October meeting showed officials leaning towards further interest rate rises. That reignited concern that borrowing costs will stay higher for longer, a worry that tends to weigh on richly valued shares. Crude oil fell about 3.2% on the day.
Asia and the day ahead
Overseas, Asian markets were uneven. Taiwan’s benchmark fell 4.6% and Australia’s ASX 200 lost about 1%. India’s Nifty 50 moved higher, finishing the session up around 0.3%.
Attention now turns to a busy Thursday. US weekly jobless claims and the Philadelphia Fed manufacturing survey are due in the morning. Walmart reports quarterly earnings before the opening bell, which will offer a fresh read on the American shopper. Anthropic is also scheduled to make its Nasdaq debut, a test of investor appetite for large technology listings.
With volatility elevated and a five-day slide behind it, the S&P 500 now needs a catalyst. Today’s data and earnings may supply one, or deepen the caution.
Market data is for information only and is not investment advice.

